HomeNewsBusinessIndiGo aims to operate domestic flights at full capacity from December 2021: Report

IndiGo aims to operate domestic flights at full capacity from December 2021: Report

“Things are improving slowly,” IndiGo CEO Ronojoy Dutta told Bloomberg Television, adding that a "bullish" target can be set as the air traffic is going up.

September 10, 2021 / 16:29 IST
Story continues below Advertisement
IndiGo is currently operating at 70 percent capacity (Representative image)
IndiGo is currently operating at 70 percent capacity (Representative image)

IndiGo, the country's largest private sector airline, is planning to operate at full capacity from December 2021, a report said on September 10. The carrier is also reportedly aiming to cover two-thirds of the international routes it operated in the pre-pandemic period.

The airline's target to return at 100 percent capacity comes amid an increase in mobility as pandemic restrictions have been eased, Bloomberg reported following its conversation with IndiGo Chief Executive Officer Ronojoy Dutta.

Story continues below Advertisement

“Things are improving slowly,” Dutta told Bloomberg Television, adding that a "bullish" target can be set as the air traffic is going up.

Also Read | Domestic air passenger traffic up 31% at 66 lakh in August on higher capacity deployment: ICRA

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show